A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This tutorial introduces the eXtreme gradient boosting (XGBoost) algorithm for drug development. It explains XGBoost concepts and implementation for classification and regression tasks, enhancing practical machine learning skills.
Area Of Science
- Computational Biology
- Pharmacology
- Data Science
Background
- Artificial intelligence and machine learning (AI/ML) are increasingly vital in modern drug development.
- A strong grasp of AI/ML principles is essential for selecting appropriate methods.
- Understanding specific algorithms like XGBoost is key for practical application.
Purpose Of The Study
- To provide a tutorial on the concepts and implementation of the eXtreme gradient boosting (XGBoost) algorithm.
- To demonstrate XGBoost's application in classification and regression using clinical trial-like datasets.
- To bridge the gap between theoretical AI/ML concepts and practical coding for drug development.
Main Methods
- Focus on the eXtreme gradient boosting (XGBoost) algorithm.
- Utilize simple clinical trial-like datasets for classification and regression tasks.
- Emphasize the connection between XGBoost's underlying concepts and its code implementation.
Main Results
- Readers will gain knowledge of the XGBoost algorithm's principles.
- Readers will learn how to implement XGBoost functions for drug development questions.
- Practical machine learning experience applicable to broader problems will be acquired.
Conclusions
- This tutorial enhances understanding and practical application of XGBoost in drug discovery.
- It equips researchers with valuable machine learning skills for clinical trial data analysis.
- The acquired knowledge facilitates the use of AI/ML in addressing complex drug development challenges.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...